L
Liminatus Pharma, Inc. (LIMN)
NGM – Real Time Price. Currency in USD
0.19
-0.01 (-6.59%)
At close: May 12, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NGM – Real Time Price. Currency in USD
0.19
-0.01 (-6.59%)
At close: May 12, 2026, 4:00 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
Total debt $1.4M significantly exceeds cash reserves ($337.7K), raising financial stability concerns
Total current liabilities $10.3M surpass Total current assets $500.6K, signaling liquidity issues
Debt-to-equity ratio (-0.1) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-46.4x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$386.9K limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 0.05 | 6.05 | 1.0 | |
| Quick ratio | 0.05 | 5.63 | 1.0 | |
| Debt to Equity | N/A | 0.30 | 1.0 | |
| Debt to Assets | 2.81 | 1.04 | 1.0 | |
| Interest coverage | -46.41 | -16.91 | 1.0 | |
| Weighted average score | 1.0 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | -2K | -2K |
| Operating Income | -2M | -3M | -3M | -3M | -3M |
| Net Income | 10M | -1M | -4M | -10M | -10M |
| EBITDA | -2M | -3M | -3M | -3M | -3M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | N/A | 1.0 |
| Next quarter | N/A | N/A | 1.0 |
| Current year | N/A | N/A | 1.0 |
| Next year | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -348.01 | N/A | 36.97 | 5.5 |
| Y/Y | 999 | -3455.53 | N/A | -175.01 | 3.3 |
| 3y average | 999 | -162.97 | N/A | -215.87 | 3.3 |
| 5y average | 999 | 67071.38 | N/A | 72.25 | 7.8 |
| Weighted average score | 5.0 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |